# Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis

> **NCT00830817** · — · COMPLETED · sponsor: **Welichem Biotech Inc.** · enrollment: 36 (actual)

## Conditions studied

- Psoriasis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00830817
- **Lead sponsor:** Welichem Biotech Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-04
- **Final completion:** 2008-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2009-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00830817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00830817, "Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00830817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*